1 Ambros V. The functions of animal microRNAs. Nature, 2004, 431: 350-355？？
[2]
2 Wang Y, Kato N, Jazag A, et al. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response.Gastroenterology, 2006, 130: 883-892？？
[3]
3 Carthew R W, Sontheimer E J. Origins and mechanisms of miRNAs and siRNAs, Cell, 2009, 136: 642-655？？
[4]
4 Kim V N. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol, 2005, 6: 376-385
[5]
5 Válóczi A, Hornyik C, Varga N, et al. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modifiedoligonucleotide probes. Nucleic Acids Res, 2004, 32: e175？？
[6]
6 Chen J, Lozach J, Garcia E W, et al. Highly sensitive and specific microRNA expression profiling using BeadArray technology. NucleicAcids Res, 2008, 36: e87
[7]
7 Mestdagh P, Feys T, Bernard N, et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of inputRNA. Nucleic Acids Res, 2008, 36: e143？？
[8]
8 Mansfield J H, Harfe B D, Nissen R, et al. MicroRNA-responsive ‘sensor’ transgenes uncover Hox-like and other developmentallyregulated patterns of vertebrate microRNA expression. Nat Genet, 2004, 36: 1079-1083？？
[9]
9 Brown B D, Gentner B, Cantore A, et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according totissue, lineage and differentiation state. Nat Biotechnol, 2007, 25: 1457-1467？？
[10]
10 Lee J Y, Kim S, Hwang do W, et al. Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis andposttranscriptional regulation. J Nucl Med, 2008, 49: 285-294？？
[11]
11 Kim H J, Chung J K, Hwang do W, et al. In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Mol Imaging Biol, 2009,11: 71-78？？
[12]
12 Barth S, Pfuhl T, Mamiani A, et al. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5.Nucleic Acids Res, 2008, 36: 666-675
[13]
13 Wurdinger T, Badr C, Pike L, et al. A secreted luciferase for ex vivo monitoring of in vivo processes. Nat Methods, 2008, 5: 171-173？？
[14]
14 Chung E, Yamashita H, Au P, et al. Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response ofsystemic metastases. PLoS One, 2009, 4: e8316？？
[15]
15 Tannous B A. Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc, 2009, 4: 582-591？？
[16]
16 Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther, 1999, 6:1258-1266？？
[17]
17 Jopling C L, Yi M, Lancaster A M, S et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science, 2005,309: 1577-1581？？
[18]
18 Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissue-specific microRNAs from mouse. Curr Biol, 2002, 12: 735-739？？
[19]
19 Brown B D, Cantore A, Annoni A, et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood,2007, 110: 4144-4152？？
[20]
20 Zhang B, Pan X. RDX induces aberrant expression of microRNAs in mouse brain and liver. Environ Health Perspect, 2009, 117: 231-240
[21]
21 Al-Dosari M, Zhang G, Knapp J E, et al. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.Biochem Biophys Res Commun, 2006, 339: 673-678？？
[22]
22 Nguyen A T, Dow A C, Kupiec-Weglinski J, et al. Evaluation of gene promoters for liver expression by hydrodynamic gene transfer. SurgRes, 2008, 148, 60-66
[23]
23 Suzuki T, Sakurai F, Nakamura S, et al. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumoreffects in suicide gene therapy. Mol Ther, 2008, 16: 1719-1726？？
[24]
24 Wolff L J, Wolff J A, Sebestyén M G. Effect of tissue-specific promoters and microRNA recognition elements on stability of transgeneexpression after hydrodynamic naked plasmid DNA delivery. Hum Gene Ther, 2009, 20: 374-388？？
[25]
25 Cawood R, Chen H H, Carroll F, et al. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation ofits ability to kill cancer cells. PLoS Pathog, 2009, 5: e1000440？？
